Plain-English translation of NCT07218666 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a clinical trial testing a medication called in men who have aggressive prostate cancer that has spread to other parts of the body and has become resistant to standard hormone therapies. You would take as a pill once per day. The trial is designed to see how well this medication works and how safe it is for this type of cancer.
Men with aggressive, advanced prostate cancer that no longer responds to current standard treatments have very limited options. Researchers are testing this medication to see if it can slow or stop the cancer's growth and help patients live longer with a better quality of life.
You likely qualify if…
You likely don't qualify if…
You would take the medication as a pill by mouth once every day, continuing as long as it seems to be helping your cancer and you are not having unmanageable side effects. You would have regular visits with the research team, including imaging scans to monitor your cancer and blood tests to check your health and how you are tolerating the treatment. The study expects to enroll about 30 men total across multiple medical centers.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
United States